Upgrade to SI Premium - Free Trial

Canaccord Genuity Raises Price target on Edwards Lifesciences (EW) as TAVI Continues to Grow

February 3, 2016 10:06 AM
Canaccord Genuity reiterated a Buy rating on Edwards Lifesciences (NYSE: EW), and raised the price target to $92.00 (from $90.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles